Purchase Order 75N91020P00675

<p>The National Cancer Institute awarded a purchase order to Novogene Corporation Inc. for $11,045.65 on August 7, 2020 for laboratory testing services. The order is firm fixed price with no set-aside category. Work is performed in Chula Vista, California, with an ultimate completion date of September 30, 2020. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Novogene Corporation Inc. for $24,700 on March 31, 2020, with completion by April 30, 2020. Work is performed in Chula Vista, California. Novogene is a minority-owned small business. The order is firm fixed price with no set-aside applied.</p>

Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order totaling $24,864 by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health. The contract calls for Novogene to provide laboratory testing services in Bethesda, Maryland, in support of the agency's biomedical research efforts. As a previous provider of genomic sequencing and bioinformatics services under over 100 federal...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Novogene Corporation Inc. for $3,886.00 on August 17, 2017. Novogene is a minority-owned small business. Performance occurs in Chula Vista, California. The order runs from August 17, 2017 through August 16, 2018 under firm fixed pricing. No set-aside designation was applied to this purchase order.</p>

<p>The National Institute on Aging issued a purchase order to Novogene Corporation Inc. on May 6, 2020, valued at $13,000.00 for genomic sequencing and bioinformatics services. The awardee is a minority-owned small business. Work is performed in Chula Vista, California. The order carries a firm fixed price and an ultimate completion date of September 30, 2020.</p>

<p>The Department of Interior's Office of Logistics and Acquisition Operations issued a purchase order to Novogene Corporation Inc. on August 29, 2017, with a ceiling value of $14,750.00. The order expires August 31, 2018. Novogene, a minority-owned small business, will perform the work at its facility in Chula Vista, California. The order is firm fixed price with no set-aside designation applied.</p>

The U.S. government awarded a $2,868.00 purchase order to Novogene Corporation Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The contract, issued on January 13, 2021, with completion targeted for July 14, 2021, covers RNA sequencing services to be performed in Chula Vista, California. This firm fixed-price purchase order was funded by a civilian federal agency and was not designated as a set-aside contract. Novogene, headquartered in...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Novogene Corporation Inc. for $13,982.00 on August 23, 2019, for RNA sequencing services. Performance is located in Bethesda, Maryland, with completion by February 28, 2020. The order is firm fixed price with no set-aside designation. Novogene is a minority-owned small business providing genomic sequencing and bioinformatics analysis.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for $17,010.00 on December 1, 2020, for mRNA sequencing services. Novogene is a minority-owned small business. Work is performed in Sacramento, California. The order is firm fixed price with an ultimate completion date of February 1, 2021.</p>

This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...